153 related articles for article (PubMed ID: 37614011)
21. Knockdown of long non-coding RNA NEAT1 inhibits glioma cell migration and invasion via modulation of SOX2 targeted by miR-132.
Zhou K; Zhang C; Yao H; Zhang X; Zhou Y; Che Y; Huang Y
Mol Cancer; 2018 Jul; 17(1):105. PubMed ID: 30053878
[TBL] [Abstract][Full Text] [Related]
22. Circular RNA XRCC5 aggravates glioma progression by activating CLC3/SGK1 axis via recruiting IGF2BP2.
Tan LM; Chen P; Nie ZY; Liu XF; Wang B
Neurochem Int; 2023 Jun; 166():105534. PubMed ID: 37061192
[TBL] [Abstract][Full Text] [Related]
23. E2F2 drives glioma progression via PI3K/AKT in a PFKFB4-dependent manner.
Zhang L; Liu Z; Dong Y; Kong L
Life Sci; 2021 Jul; 276():119412. PubMed ID: 33774025
[TBL] [Abstract][Full Text] [Related]
24. Effects of the m6Am methyltransferase PCIF1 on cell proliferation and survival in gliomas.
Gao S; Zhou J; Hu Z; Zhang S; Wu Y; Musunuru PP; Zhang T; Yang L; Luo X; Bai J; Meng Q; Yu R
Biochim Biophys Acta Mol Basis Dis; 2022 Nov; 1868(11):166498. PubMed ID: 35868483
[TBL] [Abstract][Full Text] [Related]
25. FXR1 promotes the malignant biological behavior of glioma cells via stabilizing MIR17HG.
Cao S; Zheng J; Liu X; Liu Y; Ruan X; Ma J; Liu L; Wang D; Yang C; Cai H; Li Z; Feng Z; Xue Y
J Exp Clin Cancer Res; 2019 Jan; 38(1):37. PubMed ID: 30691465
[TBL] [Abstract][Full Text] [Related]
26. MSC-AS1 knockdown inhibits cell growth and temozolomide resistance by regulating miR-373-3p/CPEB4 axis in glioma through PI3K/Akt pathway.
Li C; Feng S; Chen L
Mol Cell Biochem; 2021 Feb; 476(2):699-713. PubMed ID: 33106913
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of the aberrant A1CF-FAM224A-miR-590-3p-ZNF143 positive feedback loop attenuated malignant biological behaviors of glioma cells.
Song Y; Shao L; Xue Y; Ruan X; Liu X; Yang C; Zheng J; Shen S; Chen J; Li Z; Liu Y
J Exp Clin Cancer Res; 2019 Jun; 38(1):248. PubMed ID: 31186064
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of FOXD2-AS1 enhances proliferation and impairs differentiation of glioma stem cells by activating the NOTCH pathway via TAF-1.
Wang Y; Cheng Y; Yang Q; Kuang L; Liu G
J Cell Mol Med; 2022 May; 26(9):2620-2632. PubMed ID: 35419917
[TBL] [Abstract][Full Text] [Related]
29. Cathepsin B and uPAR regulate self-renewal of glioma-initiating cells through GLI-regulated Sox2 and Bmi1 expression.
Gopinath S; Malla R; Alapati K; Gorantla B; Gujrati M; Dinh DH; Rao JS
Carcinogenesis; 2013 Mar; 34(3):550-9. PubMed ID: 23222817
[TBL] [Abstract][Full Text] [Related]
30. SOX2-RNAi attenuates S-phase entry and induces RhoA-dependent switch to protease-independent amoeboid migration in human glioma cells.
Oppel F; Müller N; Schackert G; Hendruschk S; Martin D; Geiger KD; Temme A
Mol Cancer; 2011 Nov; 10():137. PubMed ID: 22070920
[TBL] [Abstract][Full Text] [Related]
31. Cholesterol homeostasis confers glioma malignancy triggered by hnRNPA2B1-dependent regulation of SREBP2 and LDLR.
Zhang J; Liu B; Xu C; Ji C; Yin A; Liu Y; Yao Y; Li B; Chen T; Shen L; Wu Y
Neuro Oncol; 2024 Apr; 26(4):684-700. PubMed ID: 38070488
[TBL] [Abstract][Full Text] [Related]
32. TGF-β1 secreted by M2 phenotype macrophages enhances the stemness and migration of glioma cells via the SMAD2/3 signalling pathway.
Liu Z; Kuang W; Zhou Q; Zhang Y
Int J Mol Med; 2018 Dec; 42(6):3395-3403. PubMed ID: 30320350
[TBL] [Abstract][Full Text] [Related]
33. piRNA-14633 promotes cervical cancer cell malignancy in a METTL14-dependent m6A RNA methylation manner.
Xie Q; Li Z; Luo X; Wang D; Zhou Y; Zhao J; Gao S; Yang Y; Fu W; Kong L; Sun T
J Transl Med; 2022 Jan; 20(1):51. PubMed ID: 35093098
[TBL] [Abstract][Full Text] [Related]
34. m6A regulator-mediated methylation modification patterns and characteristics of immunity and stemness in low-grade glioma.
Du J; Ji H; Ma S; Jin J; Mi S; Hou K; Dong J; Wang F; Zhang C; Li Y; Hu S
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33594424
[TBL] [Abstract][Full Text] [Related]
35. YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation.
Zhang C; Huang S; Zhuang H; Ruan S; Zhou Z; Huang K; Ji F; Ma Z; Hou B; He X
Oncogene; 2020 Jun; 39(23):4507-4518. PubMed ID: 32366907
[TBL] [Abstract][Full Text] [Related]
36. m6A methyltransferase METTL3 facilitates multiple myeloma cell growth through the m6A modification of BZW2.
Huang X; Yang Z; Li Y; Long X
Ann Hematol; 2023 Jul; 102(7):1801-1810. PubMed ID: 37222774
[TBL] [Abstract][Full Text] [Related]
37. Transcription Factor ELK3 Promotes Stemness and Oxaliplatin Resistance of Glioma Cells by Regulating RNASEH2A.
Mei Y; Chen D; He S; Ye J; Luo M; Wu Q; Huang Y
Horm Metab Res; 2023 Feb; 55(2):149-155. PubMed ID: 36638810
[TBL] [Abstract][Full Text] [Related]
38. CDK1 promotes the stemness of lung cancer cells through interacting with Sox2.
Huang Z; Shen G; Gao J
Clin Transl Oncol; 2021 Sep; 23(9):1743-1751. PubMed ID: 33721187
[TBL] [Abstract][Full Text] [Related]
39. Microrchidia family CW‑type zinc finger 2 promotes the proliferation, invasion, migration and epithelial‑mesenchymal transition of glioma by regulating PTEN/PI3K/AKT signaling via binding to N‑myc downstream regulated gene 1 promoter.
Zhang J; Yang Y; Dong Y; Liu C
Int J Mol Med; 2022 Feb; 49(2):. PubMed ID: 34913078
[TBL] [Abstract][Full Text] [Related]
40. ID4 imparts chemoresistance and cancer stemness to glioma cells by derepressing miR-9*-mediated suppression of SOX2.
Jeon HM; Sohn YW; Oh SY; Kim SH; Beck S; Kim S; Kim H
Cancer Res; 2011 May; 71(9):3410-21. PubMed ID: 21531766
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
